By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Stemedica Cell Technologies, Inc. 

5375 Mira Sorrento Place
Suite 100
San Diego  California  92121  U.S.A.
Phone: 858-658-0910 Fax: 858-658-0986


SEARCH JOBS


Industry
Suppliers






Company News
CryoPort Expands Agreement With Stemedica Cell Technologies, Inc. To Support A Phase II Clinical Trial To Assess A Stem Cell Therapy For The Treatment Of Alzheimer's Disease 8/11/2016 6:45:24 AM
Stemedica Cell Technologies, Inc. Begins First Clinical Trials In The U.S. Using Adult Allogeneic Stem Cells To Treat Alzheimer's Disease 7/27/2016 7:38:32 AM
FDA Grants IND Approval To Stemedica Cell Technologies, Inc. For A Traumatic Brain Injury Phase Ila Clinical Trial 5/18/2016 7:12:05 AM
Stemedica Cell Technologies, Inc. Announces Completion Of Enrollment In Phase I/Ila Clinical Trial For Ischemic Stroke 1/27/2016 7:28:06 AM
Stemedica Cell Technologies, Inc. Establishes Stem Cell Commercial Manufacturing Facility 11/10/2015 10:51:29 AM
CryoPort, Inc. Supports Stemedica Cell Technologies, Inc.'s Ischemic-Tolerant Stem Cell Product Lines 8/18/2015 6:49:54 AM
Stemedica Cell Technologies, Inc. Awarded U.S. Patent For Transgenic Therapeutic Stem Cells 8/13/2015 7:21:46 AM
Stemedica Cell Technologies, Inc. Release: FDA Grants IND Approval For Phase Iia Clinical Trial Using Stemedica's itMSC Therapy To Treat Alzheimer's Disease 6/9/2015 7:30:01 AM
Stemedica Cell Technologies, Inc. Obtains An Exclusive Worldwide License For Stem Cell Stabilization And Preservation Technologies 3/24/2015 11:20:20 AM
Novastem Treats First Patient Using Stemedica Cell Technologies, Inc.'s Mesenchymal And Neural Stem Cell Combination Therapy For Ischemic Stroke 12/24/2014 11:15:29 AM
1234
//-->